Open AccessEtomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma
Author(s) -
RezaAlbarrán Alfredo Adolfo,
Andino Ríos Gerson Geovany,
Gómez Herrera Laura Gabriela
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1478
Subject(s) - medicine , etomidate , refractory (planetary science) , anesthesia , cushing syndrome , propofol , physics , astrobiology
Key Clinical Message Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.